These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 18258572)
21. Prevention of osteoporosis after breast cancer. Reid DM Maturitas; 2009 Sep; 64(1):4-8. PubMed ID: 19709826 [TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole. Brufsky A; Bundred N; Coleman R; Lambert-Falls R; Mena R; Hadji P; Jin L; Schenk N; Ericson S; Perez EA; Oncologist; 2008 May; 13(5):503-14. PubMed ID: 18515735 [TBL] [Abstract][Full Text] [Related]
23. Vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis. Rovner AJ; Miller RS Pediatrics; 2008 Oct; 122(4):907-8; author reply 908-9. PubMed ID: 18829822 [No Abstract] [Full Text] [Related]
24. Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors. Clunie GP; Clark A; Mortimer CJ; Stephenson S; Aitken J; Smith C; Sherwin E; Archer TJ Eur J Surg Oncol; 2009 May; 35(5):475-80. PubMed ID: 18950981 [TBL] [Abstract][Full Text] [Related]
25. Study shows monthly vitamin D supplement effective in older women. Mayo Clin Womens Healthsource; 2009 May; 13(5):3. PubMed ID: 19349940 [No Abstract] [Full Text] [Related]
26. Compliance with the HSE policy on vitamin D supplementation for infants. McSwiney E; Moran P; Garvey A; Quet J; Kelly T; Watson M; Kiely M; Hourihane J Ir Med J; 2013 Mar; 106(3):93. PubMed ID: 23951985 [No Abstract] [Full Text] [Related]
27. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. Green D; Carson K; Leonard A; Davis JE; Rosenstein B; Zeitlin P; Mogayzel P J Pediatr; 2008 Oct; 153(4):554-9. PubMed ID: 18589445 [TBL] [Abstract][Full Text] [Related]
28. Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy. Swenson KK; Nissen MJ; Anderson E; Shapiro A; Schousboe J; Leach J J Support Oncol; 2009; 7(3):101-7. PubMed ID: 19507458 [TBL] [Abstract][Full Text] [Related]
29. Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome. Pérez-Castrillón JL; Abad L; Vega G; Sanz-Cantalapiedra A; García-Porrero M; Pinacho F; Dueñas A Eur Rev Med Pharmacol Sci; 2008; 12(2):83-8. PubMed ID: 18575157 [TBL] [Abstract][Full Text] [Related]
30. Research puts spotlight on vitamin D deficiency and cardiovascular health. Mayo Clin Womens Healthsource; 2009 Jun; 13(6):3. PubMed ID: 19415045 [No Abstract] [Full Text] [Related]
31. Perspectives on vitamin D therapy in chronic kidney disease. Karalis M Nephrol News Issues; 2008 Jul; 22(8):37, 39. PubMed ID: 18711881 [No Abstract] [Full Text] [Related]
32. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Leventis P; Kiely PD Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184 [TBL] [Abstract][Full Text] [Related]
33. Improvement of chronic back pain or failed back surgery with vitamin D repletion: a case series. Schwalfenberg G J Am Board Fam Med; 2009; 22(1):69-74. PubMed ID: 19124636 [TBL] [Abstract][Full Text] [Related]
34. Was it inappropriate to give patients with osteoporosis calcitriol instead of vitamin D? Vieth R J Am Geriatr Soc; 2008 Mar; 56(3):575-6; author reply 576-7. PubMed ID: 18315678 [No Abstract] [Full Text] [Related]
35. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism. Cozzolino M; Brancaccio D Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338 [TBL] [Abstract][Full Text] [Related]